SCHEMBL24104302

SCHEMBL24104302

Cc1cc(C)c(-c2cc(-c3cccc(-c4ccccc4C)c3)ncc2C)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 1/20 0.42
▸ KDR P35968 1/20 0.42
▸ JAK3 P52333 1/20 0.42
▸ MAPK14 Q16539 1/20 0.42
▸ ALOX5AP P20292 1/20 0.41
▸ FEN1 P39748 1/20 0.41
▸ TRPA1 O75762 1/20 0.40
▸ BRD4 O60885 1/20 0.39
▸ HTR7 P34969 3/20 0.39
▸ GRM5 P41594 1/20 0.38
▸ CTSD P07339 1/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ LDHA P00338 1/20 0.36
▸ PSMB5 P28074 1/20 0.36
▸ HTR1A P08908 1/20 0.36
▸ PDK2 Q15119 1/20 0.36
▸ TGFBR1 P36897 1/20 0.36
▸ TSHR P16473 3/20 0.35
▸ NR1H4 Q96RI1 1/20 0.35
▸ USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24105014 0.88 PSMB5 (0.44) KDRLDHAPSMB5TGFBR1
SCHEMBL22134614 0.86 LCK (0.39) LCKKDRJAK3MAPK14ALOX5AP
SCHEMBL24105023 0.83 PSMB5 (0.39) LCKKDRJAK3MAPK14ALOX5AP
SCHEMBL24104234 0.82 BRD4 (0.50) LCKKDRJAK3MAPK14TRPA1
SCHEMBL25983116 0.79 ALOX5AP (0.49) LCKKDRJAK3MAPK14ALOX5AP
SCHEMBL2484132 0.79 CYP3A4 (0.50) LCKKDRJAK3MAPK14ALOX5AP
SCHEMBL17426510 0.78 HSD17B1 (0.43) LCKKDRJAK3MAPK14ALOX5AP
SCHEMBL17426512 0.75 TGFBR1 (0.47) BRD4GRM5TGFBR1
SCHEMBL24079155 0.74 HTR7 (0.40) LCKKDRJAK3MAPK14ALOX5AP
SCHEMBL29628983 0.74 HTR7 (0.60) LCKKDRJAK3MAPK14TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 — — US disclosed
US-11725021-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-15 — — US disclosed
EP-3730506-B1 USE OF A HETEROLEPTIC COMPOUND AS AN EMITTER IN AN OLED UNIVERSAL DISPLAY CORP (US) 2021-12-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725021-B2 Organic electroluminescent materials and devices NCL, OCIAD2, OCIAD1 LCK 1803/4885KDR 2015/4885JAK3 4081/4885
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NCL, OCIAD2, OCIAD1 LCK 1803/4885KDR 2015/4885JAK3 4081/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback